Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Classification
Class II
Status
Terminated
Lot
Lot #: F201517, Exp 11/30/2024
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Lupin Pharmaceuticals Inc. — Class II Recall | MedicineWatch US